Dyne Therapeutics Files 8-K
Ticker: DYN · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1818794
| Field | Detail |
|---|---|
| Company | Dyne Therapeutics, INC. (DYN) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Dyne Therapeutics filed an 8-K, likely with important updates.
AI Summary
Dyne Therapeutics, Inc. filed an 8-K on August 4, 2025, to report on other events and a Regulation FD disclosure. The filing does not contain specific financial figures or detailed event descriptions in the provided text.
Why It Matters
This filing indicates Dyne Therapeutics is making a regulatory disclosure or reporting on an event, which could be material to investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific material information that would indicate high risk.
Key Players & Entities
- Dyne Therapeutics, Inc. (company) — Registrant
- August 4, 2025 (date) — Date of report
- 001-39509 (company) — Commission File Number
- 36-4883909 (company) — IRS Employer Identification No.
- Waltham, Massachusetts (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Dyne Therapeutics, Inc.?
The 8-K filing is for Regulation FD Disclosure and to report on Other Events.
On what date was this 8-K report filed?
The report was filed on August 4, 2025.
What is Dyne Therapeutics, Inc.'s state of incorporation?
Dyne Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for Dyne Therapeutics, Inc.?
The principal executive offices are located at 1560 Trapelo Road, Waltham, Massachusetts, 02451.
What is Dyne Therapeutics, Inc.'s telephone number?
The company's telephone number is (781) 786-8230.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Dyne Therapeutics, Inc. (DYN).